-
research project focused on mechanistic dissection of a neurodevelopmental genetic disorder and preclinical development of antisense oligonucleotide (ASO) therapeutics. The successful candidate will lead
-
modalities beyond conventional small molecules ( Genes & Development (2022) 36:1031-1042.; Genes & Development (2023) 37: 1-17). For this open position, the project direction will be focused on continuing
-
the mechanisms of human T cell development. The scientific approach to the project can be tailored to the applicant based on prior experience. Candidates with either a strong background in immunology
-
identify key drug targets for hematologic malignancies. The ultimate goal is to understand how environmental signals such as diets and nervous system activities modulate blood cell development and